0001453687-23-000089.txt : 20231115
0001453687-23-000089.hdr.sgml : 20231115
20231115172651
ACCESSION NUMBER: 0001453687-23-000089
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231113
FILED AS OF DATE: 20231115
DATE AS OF CHANGE: 20231115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davis Blaine
CENTRAL INDEX KEY: 0001802188
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37798
FILM NUMBER: 231411700
MAIL ADDRESS:
STREET 1: C/O ARTARA THERAPEUTICS, INC.
STREET 2: 1 LITTLE WEST 12TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cartesian Therapeutics, Inc.
CENTRAL INDEX KEY: 0001453687
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 65 GROVE STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-923-1400
MAIL ADDRESS:
STREET 1: 65 GROVE STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: SELECTA BIOSCIENCES INC
DATE OF NAME CHANGE: 20090109
4
1
wk-form4_1700087199.xml
FORM 4
X0508
4
2023-11-13
0
0001453687
Cartesian Therapeutics, Inc.
RNAC
0001802188
Davis Blaine
C/O CARTESIAN THERAPEUTICS, INC.
65 GROVE STREET
WATERTOWN
MA
02472
0
1
0
0
Chief Financial Officer
0
Employee Stock Option (right to buy)
1.27
2023-11-13
4
D
0
1250000
0.79
D
2032-11-27
Common Stock
1250000
0
D
This option, which provided for vesting as to 25% on November 28, 2023 with the remainder of the underlying shares vesting in 36 equal monthly installments thereafter, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc., in exchange for a cash payment of $987,500, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.
Matthew Bartholomae, Attorney-in-Fact for Blaine Davis
2023-11-15